Fit-for-purpose validation and inter-laboratory cross-validation of a TBNK flow cytometry assay with improved B cell monitoring capabilities

Home > Science Hub > Fit-for-purpose validation and inter-laboratory cross-validation of a TBNK flow cytometry assay with improved B cell monitoring capabilities
Back to the list

April 14, 2026

You might also be interested by

Brochures & Infographics

Improved whole transcriptome sequencing for challenging clinical samples: A streamlined alternative to targeted RNA-seq

June 15, 2026

More info

Posters

Advancing B-Cell Monitoring in B-Cell-Depleting Therapies for Autoimmune Disorders

June 8, 2026

More info

Uncategorized

Accelerating spectral flow cytometry assay development for clinical trials with a flexible panel design

June 8, 2026

More info

News

Leica Biosystems and CellCarta Expand Collaborative Companion Diagnostic Development Model to Accelerate Commercialization Globally

May 29, 2026

More info